"Co-Pay Relief" Program Will Help Fill Medicare Rx "Donut Hole"
This article was originally published in The Pink Sheet Daily
Executive Summary
The Patient Advocate Foundation's CPR program helps insured patients cover copayments for high-cost drugs. HHS' Office of Inspector General says the CPR program may accept funds from drug manufacturers because it will not influence patients' drug choices.
You may also be interested in...
Rx Assistance Charity May Use Manufacturer Donations For Program, IG Says
The design of the Rx assistance program would prevent donor contributions from influencing Medicare beneficiaries’ selection of product, an HHS Inspector General Advisory Opinion states. The proposed program will cover patients’ cost-sharing obligations for Medicare Part B drugs.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.